Aussie shares of AVITA Medical jump on USFDA nod for cell harvesting device

AVITA Medical

31/05/2024 01:39

** ASX-listed shares of AVITA Medical  AVH.AX  rise as much
as 19.2% to A$3.170, their biggest intraday gain since Nov. 10,
2023
    ** Stock hits its highest level since April 15
    ** U.S.-based regenerative medicine co says U.S. Food and
Drug Administration approved its premarket approval (PMA) for
its cell harvesting device for burn treatments, "RECELL GO
System" 
    ** Stock down 38% YTD as of last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))